4 weeks after being born, Freddie was diagnosed with a rare form of eye cancer. He is one of numerous babies born with rare conditions who are receiving earlier diagnoses and treatment as a result of the Generation Study. Read the full story: ow.ly/YJ7850XcTNk

Our research seminar this month will focus on the Generation Study, a landmark UK initiative exploring the feasibility, impact, and ethics of using whole-genome sequencing in newborn screening. 30 September, 14:00 - 15:00. Our seminars are open to everyone. Register for free: ow.ly/eoEt50WYb46

We are delighted to announce the appointment of Dr Natalie Banner as our Chief Ethics and Engagement Officer. In her new role, Natalie will be responsible for embedding ethics and equitable approaches across our programmes and ways of working. Read more: www.genomicsengland.co.uk/news/genomic...

Today, the government launched the Life Sciences Sector Plan - a 10-year mission to harness British science and innovation for economic growth and a stronger, prevention-focused NHS. We are proud to help make this vision a reality. Read more: www.gov.uk/government/n...

The government’s strong support for genomic healthcare in the 10 Year Health Plan is a vote of confidence in the power of genomics to transform lives. We are excited about the role we will play in bringing this to life. Read the 10 Year Health Plan here: www.gov.uk/government/p...

The Yellow Card Biobank, launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, will today start investigating genetic risk of acute pancreatitis from GLP-1 medicines, such as Ozempic and Mounjaro. Read more: ow.ly/wWHB50WgMSR @mhragovuk.bsky.social

New research led by Genomics England highlights the need for greater diversity in genetic research to make genomics’ use in cancer care and screening more accurate and reliable for all. Find out more: ow.ly/LOUj50Wcg2q

New research using data from the National Genomic Research Library describes two new genetic disorders, leading to new diagnoses for families around the world. Find out more: www.genomicsengland.co.uk/news/nationa...

New research published today has used data from Genomics England and Our Future Health to uncover how an innovative new file format could help researchers by making genomic analyses faster, cheaper, and more efficient. Find out more: ow.ly/jbk550W2rR0

We are proud to support this genomics ethics network and look forward to working collaboratively with all involved for the benefit of patients and participants 🧬

More equitable methods are needed to ensure genomic research benefits everyone fairly, according to a new review article in Nature Reviews Genetics involving Genomics England researchers. Find out more: www.nature.com/articles/s41... @natrevgenet.nature.com

We are pleased to announce the appointment of Julian Thomas as our new Chief Technology and Product Officer. Find out more about Julian, whose arrival will help us build on our achievements to date and continue making genomics more accessible for all: www.genomicsengland.co.uk/news/genomic...

Researchers have used data from the 100,000 Genomes Project to help create a ‘metal detector’ algorithm to hunt down cancer tumours. Find out more: ow.ly/Z67G50Vy0aK @cancerresearchuk.org @nihr.bsky.social

Registration is now open for the 2025 Genomics England Research Summit! Held on 17 June in London, this year’s agenda will explore groundbreaking research, technologies, and collaborations driving advances in genomic medicine. Spaces are limited, register here: ow.ly/ha8450Vlg6b #GERS2025

Are you a member of the Genomics England Research Network? Don't miss out on this incredible opportunity to showcase your research at the 2025 Genomics England Research Summit. The deadline for abstract submissions closes Thursday 20 March 2025 🔬 Submit your abstract: ow.ly/NvKk50Vb3GH #GERS2025

Today is Rare Disease Day, and the theme for this year is 'more than you can imagine', which aims to highlight the impact rare conditions can have on a person's sense of self, relationships and wellbeing. Read more here: ow.ly/6YF650V88V7 #RareDiseaseDay #MoreThanYouCanImagine

Nearly 90% of people would take a genetic test to ensure their medications work effectively and reduce the risk of side effects, according to the first national survey of public attitudes towards pharmacogenomic testing. Read the full story: ow.ly/yEvP50V3wnC

New research using data from the 100,000 Genomes Project has helped uncover what drives osteosarcoma – an aggressive bone cancer. The new insights could, with time, lead to better treatment options and outcomes for patients. Find out more: www.genomicsengland.co.uk/news/researc...

The Generation Study is a ground-breaking research study in partnership with the NHS which will sequence the whole genomes of up to 100,000 newborn babies and look for 200+ rare conditions in early childhood. Find out more: ow.ly/RVuJ50TBVQf